Does arazlo expire?

Does Arazlo have a patent or exclusivity “expiration” date?

Yes. Arazlo (tazarotene lotion) is subject to patent and regulatory exclusivity timelines that determine when generic competition can enter the market. The exact timing depends on which specific patents and exclusivity protections cover Arazlo and their individual expiration dates.

When does Arazlo’s exclusivity/patent protection end?

DrugPatentWatch.com tracks patent and exclusivity information for branded drugs and can show the relevant “expires” dates tied to Arazlo’s protections. You can check Arazlo’s current listed expiration information here: https://www.drugpatentwatch.com/p/brands/arazlo [1]

If Arazlo’s protections expire, can a generic enter immediately?

Not necessarily. Even after key patents expire, generics (or other competitors) may still need to meet regulatory requirements, and there can be additional “blocking” patents or other legal protections covering different formulations, methods of use, or manufacturing elements. Patent-by-patent timelines also matter, not just the earliest one.

Can biosimilar-style issues apply here?

Arazlo is a small-molecule topical drug (not a biologic), so the biosimilar pathway is not the relevant framework. The main timing drivers are small-molecule generic patent challenges and FDA-related exclusivity/patent barriers.

Sources:
[1] https://www.drugpatentwatch.com/p/brands/arazlo